This product is mainly composed of ulinastatin, a kind of glycoprotein extracted from fresh human urine that can inhibit the activity of various proteolytic enzymes. It belongs to protease inhibitor.
This product is white to yellowish freeze-dried lump or powder. After reconstitution, it shall be a clear liquid, colorless to yellow, with slight opalescence.
The indication for ulinastatin
1. Acute pancreatitis;
Chronic recurrent pancreatitis; 3.
3. Rescue adjuvant medication for acute circulatory failure.
(15) 50,000 units; (2) 100,000 units.
Usage and dosage of ulinastatin
1. Acute pancreatitis and chronic recurrent pancreatitis: at the initial stage, 1000 units were dissolved in 500ml 5% glucose injection or sodium chloride injection intravenously for 1 to 2 hours each time, 1 to 3 times a day, and the dosage was reduced as the symptoms subsided;
2. Acute circulative failure, 100,000 units each time dissolved in 500mL 5% glucose injection or sodium chloride injection intravenous infusion, each time static drip for 1-2 hours, 1-3 times a day, or 100,000 units each time dissolved in 5-10ml sodium chloride injection, slowly intravenous injection for 1-3 times a day. And can be based on age, symptoms appropriate increase or decrease.
Keep in a sealed, cool and dry place (no more than 20℃).